Avid Bioservices Q3 2022 Earnings Preview

Mar. 07, 2022 5:35 PM ETAvid Bioservices, Inc. (CDMO)By: SA News Team

Avid Bioservices (NASDAQ:CDMO) is scheduled to announce Q3 earnings results on Tuesday, March 8th, after market close.
The consensus EPS Estimate is $0.05 and the consensus Revenue Estimate is $25.31M
Over the last 3 months, EPS estimates have seen 3 upward revisions and 0 downward. Revenue estimates have seen 1 upward revision and 0 downward.

Recommended For You

Comments

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.